Methods to convert continuous outcomes into odds ratios of treatment response and numbers needed to treat: meta-epidemiological study
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Clinicians find standardized mean differences (SMDs) calculated from continuous outcomes difficult to interpret. Our objective was to determine the performance of methods in converting SMDs or means to odds ratios of treatment response and numbers needed to treat (NNTs) as more intuitive measures of treatment effect. METHODS: Meta-epidemiological study of large-scale trials (≥ 100 patients per group) comparing active treatment with placebo, sham or non-intervention control. Trials had to use pain or global symptoms as continuous outcomes and report both the percentage of patients with treatment response and mean pain or symptom scores per group. For each trial, we calculated odds ratios of observed treatment response and NNTs and approximated these estimates from SMDs or means using all five currently available conversion methods by Hasselblad and Hedges (HH), Cox and Snell (CS), Furukawa (FU), Suissa (SU) and Kraemer and Kupfer (KK). We compared observed and approximated values within trials by deriving pooled ratios of odds ratios (RORs) and differences in NNTs. ROR <1 and positive differences in NNTs imply that approximations are more conservative than estimates calculated from observed treatment response. As measures of agreement, we calculated intraclass correlation coefficients. RESULTS: A total of 29 trials in 13 654 patients were included. Four out of five methods were suitable (HH, CS, FU, SU), with RORs between 0.92 for SU [95% confidence interval (95% CI), 0.86-0.99] and 0.97 for HH (95% CI, 0.91-1.04) and differences in NNTs between 0.5 (95% CI, -0.1 to -1.6) and 1.3 (95% CI, 0.4-2.1). Intraclass correlation coefficients were ≥ 0.90 for these four methods, but ≤ 0.76 for the fifth method by KK (P for differences ≤ 0.027). CONCLUSIONS: The methods by HH, CS, FU and SU are suitable to convert summary treatment effects calculated from continuous outcomes into odds ratios of treatment response and NNTs, whereas the method by KK is unsuitable.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is also possible to combine relative risks with other metrics like standardised mean differences or correlation coefficients. This requires transformation from an odds ratio in a standardised mean difference (or vice versa) [86] or an odds ratio in a correlation coefficient [87,88].”
From COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) · cites this paper as [88]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471
Better Bootstrap Confidence Intervals
Efron, B. (1987) · Journal of the American Statistical Association · doi:10.1080/01621459.1987.10478410 · Cited by 3,364
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Self-citationU.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, & U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-79 · Cited by 2,856
(2008) · The Concise Encyclopedia of Statistics · doi:10.1007/978-0-387-32833-1_5 · Cited by 2,670
A Re-Evaluation of Random-Effects Meta-Analysis
Higgins, J. P. T., Thompson, S. G., & Spiegelhalter, D. J. (2009) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2008.00552.x · Cited by 2,569
Robust variance estimation in meta‐regression with dependent effect size estimates
Hedges, L. V., Tipton, E., & Johnson, M. C. (2010) · Research Synthesis Methods · doi:10.1002/jrsm.5 · Cited by 2,086
Size of Treatment Effects and Their Importance to Clinical Research and Practice
Kraemer, H. C., & Kupfer, D. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.014 · Cited by 850
Cited by
Items 101–144 of 144
Continuous outcome measures: conundrums and conversions contributing to clinical application
Mayer, M. G. (2019) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2018-111136 · Cited by 9
Boulianne, M., Verret, M., O'Connor, S. E., Savard, X., Neveu, X., Marcoux, C., Costerousse, O., Gagnon, M., Zhang, H., Beaulé, L., et al. (2025) · BMC Anesthesiology · doi:10.1186/s12871-025-03105-y · Cited by 12
“We also calculated the risk difference between groups for achieving the MCID using the Hasselblad and Hedges method to convert continuous outcome measure into dichotomous outcome measure considering our skewed data distribution [36–39].”
Oliva, C.-A., Morello, M., Kron, J., Ellenbogen, K. A., Golino, M., & Ponti, R. D. (2025) · EP Europace · doi:10.1093/europace/euaf206 · Cited by 13
“17,18 The I 2 statistic was used to assess heterogeneity among studies, with values between 25 and 50% indicating low heterogeneity, 50–75% indicating moderate heterogeneity, and values above 75% indicating high heterogeneity.”
Behavioural activation therapy for anxiety disorders in adults
Afaq, S., Uphoff, E., Borle, A. L., Brown, J. V. E., Coales, K., Dawson, S., Elduma, A. H., Iqbal, M., Jarde, A., Koly, K. N., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015026 · Cited by 11
Nielsen, S. M., Storgaard, H., Ellingsen, T., Shea, B., Wells, G. A., Welch, V. A., Furst, D. E., de Wit, M. P. T., Voshaar, M., Juhl, C. B., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217237 · Cited by 9
Eddy, E., Heron, P., McMillan, D., Dawson, S., Ekers, D., Hickin, N., Littlewood, E., Shafran, R., Meader, N., & Gilbody, S. M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013791 · Cited by 7
Gauging the impact of behavior change interventions: A tutorial on the Numbers Needed to TreatPreprint
Gruijters, S. L. K., & Peters, G.-J. (2017) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/2bau7 · Cited by 7
Vancak, V., Goldberg, Y., & Levine, S. Z. (2022) · Statistics in Medicine · doi:10.1002/sim.9418 · Cited by 5
Li, Y., Liu, Y., Liu, X., Zhang, T., Guo, Z., Lai, L., Zhao, J., Cheng, Y., & Ren, Z. (2025) · Health Psychology Review · doi:10.1080/17437199.2025.2493903 · Cited by 6
“One possible explanation is that studies with larger sample sizes may provide more robust estimates of e ff ect sizes due to increased statistical power (da Costa et al., 2012), leading to more reliable and stable results.”
Jing, Y., Murad, M. H., & Lin, L. (2022) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2022.2105345 · Cited by 5
“This method has been widely used in the current practice of meta-analyses, and it has been shown to perform adequately well compared with other alternatives (Anzures-Cabrera et al. 2011; da Costa et al. 2012; Mayer 2019).”
MethodSiafis, S., Nomura, N., Schneider‐Thoma, J., Bighelli, I., Bannach‐Brown, A., Ramage, F. J., Tinsdeall, F., Mantas, I., Jauhar, S., Natesan, S., et al. (2024) · F1000Research · doi:10.12688/f1000research.155356.1 · Cited by 3
Behavioural activation therapies for depression in adults with non-communicable diseases
Uphoff, E., Pires, M., Barbui, C., Barua, D., Churchill, R. C., Ekers, D., Fottrell, E. F., Mazumdar, P., Purgato, M., Rana, R. Z., et al. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013461 · Cited by 4
“Cochrane Database of Systematic Reviews Furukawa and colleagues to impute SDs and calculate percentage responders (da Costa 2012; Furukawa 2005; Furukawa 2006).”
BackgroundThe Evergreening of Biopharmaceuticals: Time to Defoliate
Lehmann, D. F., & Wojnowicz, S. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.642 · Cited by 3
Surgical clinical trials with non-inferiority design: a cross-sectional bibliometric analysis
Shu, C., Huang, B., Yuan, D., Yang, Y., Du, X., He, Y., Chen, X., & Zhao, J. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2626 · Cited by 3
“With regard to studies using continuous effect estimates such as mean differences as the primary outcome, we standardized the effect estimates with the reported standard deviations (SD), and then transformed the continuous estimates to ORs following the Hasselblad and Hedges’ method (11,12).”
MethodKampe, R. T., Nielsen, S. M., Hotea, I., van Durme, C. M., Christensen, R., & Boonen, A. E. R. C. H. (2022) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2022.152049 · Cited by 2
Mickenautsch, S., & Yengopal, V. (2014) · Journal of minimum intervention in dentistry · Cited by 2
He, Y., Shu, C., Li, T., Wu, Q., Wang, Z., Chen, X., & Shen, X. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.08.020 · Cited by 3
Systematic Reviews of Nonrandomized Studies of Interventions
Savović, J., Whiting, P. F., & Dekkers, O. M. (2022) · Wiley eBooks · doi:10.1002/9781119099369.ch15 · Cited by 2
Number Needed to Treat: Overview
Bender, R. (2017) · Wiley eBooks · doi:10.1002/9781118445112.stat04972.pub2 · Cited by 2
Bhushan, V., & Sindhu, R. K. (2024) · Journal of Natural Remedies · doi:10.18311/jnr/2024/43424 · Cited by 1
Zhang, X., Wei, G., Zhang, X., Guo, J., Zhao, J., Li, X., Zhao, X., Shi, J., Yang, Y., Su, F., et al. (2025) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.70050 · Cited by 2
Vancak, V., & Sjölander, A. (2024) · Epidemiologic Methods · doi:10.1515/em-2023-0034 · Cited by 2
Cheng, F., & Zhang, J. (2020) · Springer eBooks · doi:10.1007/978-981-15-5975-4_8 · Cited by 1
Estimating Response Ratios from Continuous Outcome Data
Gåsemyr, J., Natvig, B., & Tvete, I. F. (2014) · Methodology And Computing In Applied Probability · doi:10.1007/s11009-014-9408-5 · Cited by 1
Systematic Reviews and Meta-Analytic Methods in Clinical Psychology
Cuijpers, P. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818697-8.00157-6
Liberty, Equality and Fairness: A Study of Citizen Participation in Federal Agency Rulemaking
Engram, T. E. (2008) · Digital Archive @ GSU · doi:10.57709/1059869 · Cited by 1
Optimizing the management of patients with gout in daily practice
Kampe, R. T. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20221103rk
Chiocchia, V., Furukawa, T. A., Schneider‐Thoma, J., Siafis, S., Cipriani, A., Leucht, S., & Salanti, G. (2023) · Systematic Reviews · doi:10.1186/s13643-023-02376-1
Definition, identification, and estimation of the direct and indirect number needed to treat
Vancak, V., & Sjölander, A. (2025) · Epidemiologic Methods · doi:10.1515/em-2025-0018
Ramanathan, G., Sivaraman, D., & Haridas, A. (2025) · Metabolomics · doi:10.1007/s11306-025-02365-6
“Therefore, the comparability and reliability of meta-analysis are acceptable (da Costa et al. 2012).”
Mean Differences and Standard Mean Difference: Important Differences in Quality of Life
Davis, M. P. (2025) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2025.11.021
Chiocchia, V., Furukawa, T. A., Schneider‐Thoma, J., Siafis, S., Cipriani, A., Leucht, S., & Salanti, G. (2024) · Figshare · doi:10.6084/m9.figshare.26638620
Chiocchia, V., Furukawa, T. A., Schneider‐Thoma, J., Siafis, S., Cipriani, A., Leucht, S., & Salanti, G. (2024) · Figshare · doi:10.6084/m9.figshare.26638608
Chiocchia, V., Furukawa, T. A., Schneider‐Thoma, J., Siafis, S., Cipriani, A., Leucht, S., & Salanti, G. (2024) · Figshare · doi:10.6084/m9.figshare.24548177
Chiocchia, V., Furukawa, T. A., Schneider‐Thoma, J., Siafis, S., Cipriani, A., Leucht, S., & Salanti, G. (2024) · Figshare · doi:10.6084/m9.figshare.26638614
Long, J., Yang, Z., Wang, L., Han, Y., Peng, C., Yan, C., & Yan, D. (2020) · Figshare · doi:10.6084/m9.figshare.13278707
Chiocchia, V., Furukawa, T. A., Schneider‐Thoma, J., Siafis, S., Cipriani, A., Leucht, S., & Salanti, G. (2024) · Figshare · doi:10.6084/m9.figshare.26638626
Chiocchia, V., Furukawa, T. A., Schneider‐Thoma, J., Siafis, S., Cipriani, A., Leucht, S., & Salanti, G. (2023) · Figshare · doi:10.6084/m9.figshare.24548147
Chiocchia, V., Furukawa, T. A., Schneider‐Thoma, J., Siafis, S., Cipriani, A., Leucht, S., & Salanti, G. (2024) · Figshare · doi:10.6084/m9.figshare.26638617
Chiocchia, V., Furukawa, T. A., Schneider‐Thoma, J., Siafis, S., Cipriani, A., Leucht, S., & Salanti, G. (2024) · Figshare · doi:10.6084/m9.figshare.26638623
Chiocchia, V., Furukawa, T. A., Schneider‐Thoma, J., Siafis, S., Cipriani, A., Leucht, S., & Salanti, G. (2024) · Figshare · doi:10.6084/m9.figshare.26638611
Bharath Kumar, G., Jain, M., Meher, B. R., Padhy, B. M., Sakale, H. S., & Kumar, S. (2026) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-026-04073-z · Cited by 1
“The approach described by da Costa et al. (2012) [25 ] was used to convert continuous data into responder pro - portions, with a clinically meaningful response defined as a reduction of at least 50% from baseline.”
Zhang, Y., Zhao, Y., Cheng, Y., Liu, L., Wang, Z., & Wu, B. (2026) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2026.102060
Kim, M. S., Hwang, Y., Son, Y., Jo, Y., Kim, H. J., Smith, L., López-Gil, J. F., Kim, S., Hwang, H. S., Yon, D. K., et al. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.143013
Metadata
- Authors
- da Costa, B. R., Rutjes, A. W., Johnston, B. C., Reichenbach, S., Nüesch, E., Tonia, T., Gemperli, A., Guyatt, G. H., & Jüni, P.
- Affiliations
- University of Bern (CH)
- Corresponding author
- Jüni, Peter
- ORCID
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-10
- Volume
- 41
- Issue
- 5
- Pages
- 1445-1459
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2113028645
- Cited by
- 145
- References
- 34
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 15 · 2023: 8 · 2022: 14 · 2021: 13 · 2020: 16 · 2019: 12 · 2018: 8 · 2017: 12 · 2016: 6 · 2015: 7 · 2014: 8 · 2013: 11 · 2012: 1
- FWCI
- 9.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- International Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- reroDoc Digital Library (submittedVersion)
- BORIS (University Library Bern) (submittedVersion, other-oa)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- HighWire Press Open Archive (submittedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
- Open Access CRIS of the University of Bern
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Keywords
- number needed to treat, standardized mean difference, conversion method, continuous outcomes, treatment response, pain, meta-epidemiology, measurement agreement
- MeSH terms
- Clinical Trials as Topic, Data Interpretation, Statistical, Humans, Research Design, Odds Ratio, Pain Management, Numbers Needed To Treat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.